Home>Topics>>For Biotech Investors: 5 Orphan Drugs And Their Parent Companies
For Biotech Investors: 5 Orphan Drugs And Their Parent Companies
Healthcare Sector and Stocks Analysis from Seeking Alpha
Thu, 8 Nov 2012
By Brian L. Wilson : This year, one of many trends in the world of biotech investing is the increasing popularity of orphan drugs on Wall Street. An orphan drug is a special designation that is given to drugs that are intended to treat very rare diseases (in the United States this means less than ...
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.